Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease
- PMID: 2648384
- PMCID: PMC286800
- DOI: 10.1073/pnas.86.6.1841
Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease
Abstract
Recombinant human immunodeficiency virus 1 (HIV-1) protease, purified from a bacterial expression system, processed a recombinant form of its natural substrate, Pr55gag, into protein fragments that possess molecular weights commensurate with those of the virion gag proteins. Molecular weights of the protease obtained under denaturing and nondenaturing conditions (11,000 and 22,000, respectively) and chemical crosslinking studies were consistent with a dimeric structure for the active enzyme. The protease appropriately cleaved the nonapeptide Ac-Arg-Ala-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 between the tyrosine and proline residues. HIV-1 protease was sensitive to inactivators of the aspartic proteases. The aspartic protease inactivator 1,2-epoxy-3-(4-nitrophenoxy)propane produced irreversible, time-dependent inactivation of the protease. The pH-dependent kinetics of this inactivator were consistent with the requirement of an unprotonated carboxyl group in the active site of the enzyme, suggesting that HIV-1 protease is also an aspartic protease.
Similar articles
-
Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.Biochemistry. 1991 Aug 27;30(34):8424-34. doi: 10.1021/bi00098a021. Biochemistry. 1991. PMID: 1883829
-
Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.Biochemistry. 1990 Jan 9;29(1):264-9. doi: 10.1021/bi00453a036. Biochemistry. 1990. PMID: 2182116
-
Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease.J Biol Chem. 1989 Feb 5;264(4):2307-12. J Biol Chem. 1989. PMID: 2644259
-
Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.Proc Natl Acad Sci U S A. 1987 Dec;84(24):8903-6. doi: 10.1073/pnas.84.24.8903. Proc Natl Acad Sci U S A. 1987. PMID: 3321060 Free PMC article.
-
Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro.J Biol Chem. 1990 Aug 15;265(23):13890-8. J Biol Chem. 1990. PMID: 2199446
Cited by
-
Identification and characterization of human immunodeficiency virus type 1 gag-pol fusion protein in transfected mammalian cells.J Virol. 1991 May;65(5):2751-6. doi: 10.1128/JVI.65.5.2751-2756.1991. J Virol. 1991. PMID: 1707986 Free PMC article.
-
Stability and activity of human immunodeficiency virus protease: comparison of the natural dimer with a homologous, single-chain tethered dimer.Proc Natl Acad Sci U S A. 1990 Dec;87(24):9660-4. doi: 10.1073/pnas.87.24.9660. Proc Natl Acad Sci U S A. 1990. PMID: 2263618 Free PMC article.
-
HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells.Cancers (Basel). 2022 Dec 30;15(1):238. doi: 10.3390/cancers15010238. Cancers (Basel). 2022. PMID: 36612231 Free PMC article.
-
Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease.ACS Infect Dis. 2019 Feb 8;5(2):316-325. doi: 10.1021/acsinfecdis.8b00336. Epub 2018 Dec 31. ACS Infect Dis. 2019. PMID: 30543749 Free PMC article.
-
Sequence requirements of the HIV-1 protease flap region determined by saturation mutagenesis and kinetic analysis of flap mutants.Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2243-8. doi: 10.1073/pnas.94.6.2243. Proc Natl Acad Sci U S A. 1997. PMID: 9122179 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources